Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume 14, Issue 6, Pages 684-691
Publisher
Springer Nature
Online
2012-09-18
DOI
10.1007/s11886-012-0317-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consistency of Extended-Release Niacin/Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups
- (2012) Harold E. Bays et al. American Journal of Cardiovascular Drugs
- Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
- (2012) Thomas F. Lüscher et al. EUROPEAN HEART JOURNAL
- Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice
- (2012) Yuan Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake: Still problematic after the primary publication
- (2012) Eliot A. Brinton Journal of Clinical Lipidology
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Evacetrapib
- (2012) Stephen J. Nicholls Current Cardiology Reports
- Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
- (2011) Hayes M. Dansky et al. AMERICAN HEART JOURNAL
- Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments
- (2011) Janet E. Digby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis
- (2011) Chiara Giannarelli et al. EUROPEAN HEART JOURNAL
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
- (2011) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
- (2011) Martina Lukasova et al. JOURNAL OF CLINICAL INVESTIGATION
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
- (2011) Katey J. Rayner et al. JOURNAL OF CLINICAL INVESTIGATION
- Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters
- (2011) Jose Castro-Perez et al. JOURNAL OF LIPID RESEARCH
- Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
- (2011) Ronald M. Krauss et al. JOURNAL OF LIPID RESEARCH
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease
- (2011) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
- (2011) Zahi A Fayad et al. LANCET
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
- (2011) Katey J. Rayner et al. NATURE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In Vivo
- (2010) Tomoyuki Yasuda et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
- (2010) JWA van der Hoorn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
- (2010) Evan A. Stein et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia
- (2010) S. Shah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of Niacin Therapy on Cardiovascular Outcomes in Patients With Coronary Artery Disease
- (2010) Jasleen K. Duggal et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Seeing red: flushing out instigators of niacin-associated skin toxicity
- (2010) Richard L. Dunbar et al. JOURNAL OF CLINICAL INVESTIGATION
- Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
- (2010) Julien Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome
- (2010) Harold E. Bays et al. Journal of Clinical Lipidology
- Biochemical characterization of cholesteryl ester transfer protein inhibitors
- (2010) Mollie Ranalletta et al. JOURNAL OF LIPID RESEARCH
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
- (2010) Todd C. Villines et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
- (2010) Ron Waksman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
- (2009) Christopher P. Cannon et al. AMERICAN HEART JOURNAL
- Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
- (2009) Philip Barter AMERICAN JOURNAL OF CARDIOLOGY
- Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
- (2009) Darbie Maccubbin et al. AMERICAN JOURNAL OF CARDIOLOGY
- Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia
- (2009) Sergio Fazio et al. AMERICAN JOURNAL OF CARDIOLOGY
- Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano
- (2009) Eric T. Alexander et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
- (2009) Eric Bruckert et al. ATHEROSCLEROSIS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
- (2009) Anna C. Calkin et al. CIRCULATION
- Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model
- (2009) François Briand et al. JOURNAL OF LIPID RESEARCH
- Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
- (2009) Frank M. Sacks et al. JOURNAL OF LIPID RESEARCH
- Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
- (2009) Sanjay Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
- (2008) Daniel Bloomfield et al. AMERICAN HEART JOURNAL
- Cholesteryl Ester Transfer Protein (CETP) Inhibitors: Is There Life After Torcetrapib?
- (2008) Hemanth Neeli et al. CARDIOLOGY CLINICS
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
- (2008) Eseng Lai et al. Journal of Clinical Lipidology
- Dose-Related Effects of Repeated ETC-216 (Recombinant Apolipoprotein A-IMilano/1-Palmitoyl-2-Oleoyl Phosphatidylcholine Complexes) Administrations on Rabbit Lipid-Rich Soft Plaques
- (2008) Cinzia Parolini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Beyond High-Density Lipoprotein Cholesterol Levels
- (2008) Emil M. deGoma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now